In 2024, the trade exchange (includes international purchases and sales) of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins was US$8.22M.
In 2023, the states with the most international sales in D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins were Jalisco (US$103k).
The states with the most international purchases in 2024 were Jalisco (US$4.01M), Ciudad de México (US$1.99M), Querétaro (US$817k), Nuevo León (US$465k), and Estado de México (US$205k).
In 2023, the main commercial destinations of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins were El Salvador (US$81.6k), Guatemala (US$8.48k), Barbados (US$6.32k), Jamaica (US$4.49k), and Brazil (US$1.91k).
The main commercial origins of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins in 2024 were China (US$3.85M), United Kingdom (US$2.51M), Germany (US$1.22M), Thailand (US$26.3k), and United States (US$2.17k).
In the global context, the main exporting countries of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins in 2022 were China (US$311M), United Kingdom (US$116M), and Netherlands (US$106M). In the same year, the main importing countries of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins were United States (US$99M), Netherlands (US$46M), and Belgium (US$41.3M).